Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions

This study has been completed.
Information provided by:
Ranbaxy Inc. Identifier:
First received: October 22, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2002
  Primary Completion Date: October 2002 (Final data collection date for primary outcome measure)